title: Management of pediatric chronic spontaneous and physical urticaria patients with omalizumab: case series.
authors.affiliation: Division of Dermatology, McGill University Health Centre, Montreal, QC, Canada.
authors.forename: Elena
authors.initials: E
authors.lastname: Netchiporouk
authors.affiliation: Division of Dermatology, McGill University Health Centre, Montreal, QC, Canada.
authors.forename: Christopher H
authors.initials: CH
authors.lastname: Nguyen
authors.affiliation: Division of Dermatology, McGill University Health Centre, Montreal, QC, Canada.
authors.forename: Thusanth
authors.initials: T
authors.lastname: Thuraisingham
authors.affiliation: Division of Dermatology, McGill University Health Centre, Montreal, QC, Canada.
authors.forename: Fatemeh
authors.initials: F
authors.lastname: Jafarian
authors.affiliation: Department of Dermatology and Allergy, Charité Universitätsmedizin, Berlin, Germany.
authors.forename: Marcus
authors.initials: M
authors.lastname: Maurer
authors.affiliation: Department of Pediatrics, Division of Allergy and Clinical Immunology, McGill University Health Centre, Montreal, QC, Canada. moshebenshoshan@gmail.com.
authors.forename: Moshe
authors.initials: M
authors.lastname: Ben-Shoshan
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D007279:Injections, Subcutaneous; D008297:Male; D000069444:Omalizumab / Q000008:administration & dosage / Q000627:therapeutic use*; D012074:Remission Induction; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome; D014581:Urticaria / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D007155:Immunologic Factors; D000069444:Omalizumab